Search - tctmd.com

Displaying 1 - 20 of 39

Sort: Relevancy | Date

News Conference News TCT 2016

Cancer Patients Face Increased Risk of Acute MI, More PCI Complications, Higher Mortality, and Soaring Costs

Michael H. Wilson

October 31, 2016

News Daily News

MI Patients Who Develop Heart Failure Vulnerable to Higher Risk of Cancer

Michael H. Wilson

July 13, 2016

Presentation Fellows 2016

State-of-the-Art in ACS and STEMI: Risk Stratification and Reperfusion Strategies

Presenter: Gregg Stone

April 15, 2016

Presentation Fellows 2016

Atherosclerosis, Vulnerable Plaque, and How We Evaluate Devices in the Preclinical Setting

Presenter: Kevin Croce

April 15, 2016

Presentation Fellows 2016

ACS Case 3: AMI Complication

Presenter: Manish Parikh

April 15, 2016

Presentation Fellows 2016

ACS Case 2: STEMI

Presenter: Robert Yeh

April 15, 2016

Presentation Fellows 2016

ACS Case 1: NSTEMI

Presenter: Kevin Croce

April 15, 2016

Presentation Fellows 2015

How to Navigate the New Oral Anticoagulants and Deal With Triple Therapy

Presenter: Manish A. Parikh, Roxana Mehran

May 15, 2015

Presentation Fellows 2015

Antithrombin Pharmacology for the Interventionalist

Presenter: Manish A. Parikh, Roxana Mehran, David J. Cohen

May 15, 2015

Presentation Fellows 2015

Antiplatelet Therapy for the Interventionalist

Presenter: Manish A. Parikh, Roxana Mehran, Gregg W. Stone

May 15, 2015

Presentation Fellows 2015

ACS Case 3: AMI Complication

Presenter: Manish A. Parikh

May 15, 2015

Presentation Fellows 2015

ACS Case 2: STEMI

Presenter: Robert W. Yeh

May 15, 2015

Presentation Fellows 2015

ACS Case 1: NSTEMI

Presenter: Kevin J. Croce

May 15, 2015

Presentation Fellows 2015

State-of-the-Art in ACS and STEMI: Risk Stratification and Reperfusion Strategies

Presenter: Ajay J. Kirtane, Mauricio G. Cohen, Gregg W. Stone

May 15, 2015

Advertisement

Cancer Patients Face Increased Risk of Acute MI, More PCI Complications, Higher Mortality, and Soaring Costs

MI Patients Who Develop Heart Failure Vulnerable to Higher Risk of Cancer

State-of-the-Art in ACS and STEMI: Risk Stratification and Reperfusion Strategies

Atherosclerosis, Vulnerable Plaque, and How We Evaluate Devices in the Preclinical Setting

ACS Case 3: AMI Complication

ACS Case 2: STEMI

ACS Case 1: NSTEMI

How to Navigate the New Oral Anticoagulants and Deal With Triple Therapy

Antithrombin Pharmacology for the Interventionalist

Antiplatelet Therapy for the Interventionalist

ACS Case 3: AMI Complication

ACS Case 2: STEMI

ACS Case 1: NSTEMI

State-of-the-Art in ACS and STEMI: Risk Stratification and Reperfusion Strategies

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content